UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma

Neuro-oncology (Charlottesville, Va.), 2017-07, Vol.19 (7), p.965-975

2017

Volltextzugriff (PDF)

A Phase 1 and Biodistribution Study of ABT-806i, an 111 In-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806

Journal of Nuclear Medicine, 2021-06, Vol.62 (6), p.787-794

2021

Volltextzugriff (PDF)

A Phase 1 and Biodistribution Study of ABT-806i, an 111In-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806

The Journal of nuclear medicine (1978), 2021-06, Vol.62 (6), p.787

2021

Volltextzugriff (PDF)

Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma

Neuro-oncology (Charlottesville, Va.), 2018-05, Vol.20 (6), p.838-847

2018

Volltextzugriff (PDF)

Phase I study of the antibody-drug conjugate ABBV-321 in patients with non-small cell lung cancer and squamous head and neck cancer with overexpression of the epidermal growth factor receptor

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS3649-TPS3649

2020

Volltextzugriff (PDF)

PDCT-02. EVALUATION OF DEPATUXIZUMAB MAFODOTIN (ABT-414) IN CHILDREN WITH HIGH GRADE GLIOMA (HGG) AND DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi183-vi184

2017

Volltextzugriff (PDF)

PATH-29. MOLECULAR DETERMINANTS ASSOCIATED WITH RESPONSE AND RESISTANCE TO DEPATUXIZUMAB MAFODOTIN (ABT-414) IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi176-vi177

2017

Volltextzugriff (PDF)

HG-44EVALUATION OF ABT-414 IN CHILDREN WITH HIGH GRADE GLIOMA (HGG) AND DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

Neuro-oncology (Charlottesville, Va.), 2016-06, Vol.18 (suppl 3), p.iii57.2-iii57

2016

Volltextzugriff (PDF)

A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806

The Journal of nuclear medicine (1978), 2021-01

2021

Volltextzugriff (PDF)

Phase I study of ABT-414 mono- or combination therapy with temozolomide (TMZ) in recurrent glioblastoma (GBM)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2016-2016

2015

Volltextzugriff (PDF)

ABT-414 in patients with advanced solid tumors likely to overexpress the epidermal growth factor receptor (EGFR)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2510-2510

2015

Volltextzugriff (PDF)

A phase 1 study evaluating ABT-414 in combination with temozolomide (TMZ) for subjects with recurrent or unresectable glioblastoma (GBM)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2021-2021

2014

Volltextzugriff (PDF)

ATNT-02DETERMINANTS OF RESPONSES AND RESISTANCE TO ABT-414: RESULTS OF NEXT-GENERATION SEQUENCING

Neuro-oncology (Charlottesville, Va.), 2015-11, Vol.17 (suppl 5), p.v10.2-v10

2015

Volltextzugriff (PDF)

ATNT-01ABT-414 MONO- OR COMBINATION THERAPY WITH TEMOZOLOMIDE (TMZ) RECHALLENGE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) AND AMPLIFIED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR): A PHASE I STUDY

Neuro-oncology (Charlottesville, Va.), 2015-11, Vol.17 (suppl 5), p.v10.1-v10

2015

Volltextzugriff (PDF)

Randomized Phase II Open-Label Study of mFOLFOX6 in Combination With Linifanib or Bevacizumab for Metastatic Colorectal Cancer

Clinical colorectal cancer, 2014-09, Vol.13 (3), p.156-163.e2

2014

Volltextzugriff (PDF)

Absorption and disposition of a selective aldosterone receptor antagonist, eplerenone, in the dog

Pharmaceutical research, 2000-11, Vol.17 (11), p.1426-1431

2000

Volltextzugriff (PDF)

ET-19A PHASE 1 STUDY EVALUATING ABT-414 WITH TEMOZOLOMIDE (TMZ) OR CONCURRENT RADIOTHERAPY (RT) AND TMZ IN GLIOBLASTOMA (GBM)

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v83-v83

2014

Volltextzugriff (PDF)

ET-19 A PHASE 1 STUDY EVALUATING ABT-414 WITH TEMOZOLOMIDE (TMZ) OR CONCURRENT RADIOTHERAPY (RT) AND TMZ IN GLIOBLASTOMA (GBM)

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v83-v83

2014

Volltextzugriff (PDF)

Testing the Interactivity Principle: Effects of Mediation, Propinquity, and Verbal and Nonverbal Modalities in Interpersonal Interaction

Journal of communication, 2002-09, Vol.52 (3), p.657-677

2002

Volltextzugriff (PDF)

Testing the Interactivity Principle: Effects of Mediation, Propinquity, and Verbal and Nonverbal Modalities in Interpersonal Interaction

Journal of communication, 2002-09, Vol.52 (3), p.657

2002

Volltextzugriff (PDF)

The Green Housing Privilege? An Analysis of the Connections Between Socio-Economic Status of California Communities and Leadership in Energy and Environmental Design (LEED) Certification

Journal of sustainable development, 2013-05, Vol.6 (5), p.37-49

2013

Volltextzugriff (PDF)

Research on the Relationship Between Verbal and Nonverbal Communication: Emerging Integrations

Journal of communication, 2002-09, Vol.52 (3), p.499-521

2002

Volltextzugriff (PDF)

Testing the interactivity principle: Effects of mediation, propinquity, and verbal and nonverbal modalities in interpersonal interaction: Research on the relationship between verbal and nonverbal communication: emerging integrations

Journal of communication, 2002, Vol.52 (3), p.657-677

2002

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(6)
Science & Technology
(6)
Abstracts
(4)
Oncology
(4)
Antibody-Drug Conjugate
(3)
Communication
(3)
Egfr
(3)
Female
(3)
Male
(3)
Patients
(3)
Pharmacokinetics
(3)
Abstracts From The 20th Annual Scientific Meeting Of The Society For Neuro-Oncology
(2)
Abt-414
(2)
Adult
(2)
Aged
(2)
Clinical Investigations
(2)
Clinical Neurology
(2)
Communication Research
(2)
Disease-Free Survival
(2)
Drug Dosages
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety results of depatuxizumab mafodotin (ABT‐414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor

Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma

A Phase 1 and Biodistribution Study of ABT-806i, an 111 In-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806

A Phase 1 and Biodistribution Study of ABT-806i, an 111In-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806

Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma

Phase I study of the antibody-drug conjugate ABBV-321 in patients with non-small cell lung cancer and squamous head and neck cancer with overexpression of the epidermal growth factor receptor

PDCT-02. EVALUATION OF DEPATUXIZUMAB MAFODOTIN (ABT-414) IN CHILDREN WITH HIGH GRADE GLIOMA (HGG) AND DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

PATH-29. MOLECULAR DETERMINANTS ASSOCIATED WITH RESPONSE AND RESISTANCE TO DEPATUXIZUMAB MAFODOTIN (ABT-414) IN PATIENTS WITH RECURRENT GLIOBLASTOMA

HG-44EVALUATION OF ABT-414 IN CHILDREN WITH HIGH GRADE GLIOMA (HGG) AND DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806

Phase I study of ABT-414 mono- or combination therapy with temozolomide (TMZ) in recurrent glioblastoma (GBM)

ABT-414 in patients with advanced solid tumors likely to overexpress the epidermal growth factor receptor (EGFR)

A phase 1 study evaluating ABT-414 in combination with temozolomide (TMZ) for subjects with recurrent or unresectable glioblastoma (GBM)

ATNT-02DETERMINANTS OF RESPONSES AND RESISTANCE TO ABT-414: RESULTS OF NEXT-GENERATION SEQUENCING

ATNT-01ABT-414 MONO- OR COMBINATION THERAPY WITH TEMOZOLOMIDE (TMZ) RECHALLENGE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) AND AMPLIFIED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR): A PHASE I STUDY

Randomized Phase II Open-Label Study of mFOLFOX6 in Combination With Linifanib or Bevacizumab for Metastatic Colorectal Cancer

Absorption and disposition of a selective aldosterone receptor antagonist, eplerenone, in the dog

ET-19A PHASE 1 STUDY EVALUATING ABT-414 WITH TEMOZOLOMIDE (TMZ) OR CONCURRENT RADIOTHERAPY (RT) AND TMZ IN GLIOBLASTOMA (GBM)

ET-19 A PHASE 1 STUDY EVALUATING ABT-414 WITH TEMOZOLOMIDE (TMZ) OR CONCURRENT RADIOTHERAPY (RT) AND TMZ IN GLIOBLASTOMA (GBM)

Testing the Interactivity Principle: Effects of Mediation, Propinquity, and Verbal and Nonverbal Modalities in Interpersonal Interaction

Testing the Interactivity Principle: Effects of Mediation, Propinquity, and Verbal and Nonverbal Modalities in Interpersonal Interaction

The Green Housing Privilege? An Analysis of the Connections Between Socio-Economic Status of California Communities and Leadership in Energy and Environmental Design (LEED) Certification

Research on the Relationship Between Verbal and Nonverbal Communication: Emerging Integrations

Testing the interactivity principle: Effects of mediation, propinquity, and verbal and nonverbal modalities in interpersonal interaction: Research on the relationship between verbal and nonverbal communication: emerging integrations

Suchergebnisse filtern